Javier Sanz-Marco

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity.

Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity.

Journal: Cancer cell
Published: December 17, 2024

Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas.

Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas.

Journal: Cell reports. Medicine
Published: October 08, 2024

Radiotherapy protocols for mouse cancer model.

Radiotherapy protocols for mouse cancer model.

Journal: Methods in cell biology
Published: March 31, 2024

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.

Journal: Neuro-oncology
Published: March 30, 2024

Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models.

Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models.

Journal: JCI insight
Published: August 29, 2023

Set Protein Is Involved in FLT3 Membrane Trafficking.

Set Protein Is Involved in FLT3 Membrane Trafficking.

Journal: Cancers
Published: February 27, 2023

Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma.

Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma.

Journal: Molecular therapy oncolytics
Published: April 04, 2022

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas.

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas.

Journal: JCI insight
Published: September 14, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026